Fibromyalgia Syndrome and Chronic Pelvic Pain

Relationship Between Fibromyalgia Syndrome and Chronic Pelvic Pain: A Cross-Sectional Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07344675

Enrollment

128

Registered

2026-01-15

Start date

2025-07-01

Completion date

2026-02-01

Last updated

2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain, Chronic Pelvic Pain Syndrome (CPPS), Fibromyalgia, Fibromyalgia Syndrome, Pain

Keywords

fibromyalgia, chronic pelvic pain, pain

Brief summary

This study aimed to compare patients with and without fibromyalgia syndrome in terms of chronic pelvic pain and pelvic floor dysfunction.

Detailed description

The study planned for two patient groups in the Physical Medicine and Rehabilitation outpatient clinic: female patients followed up for fibromyalgia and a control group matched for age and gender without fibromyalgia syndrome. Demographic data, symptom duration, chronic pelvic pain, and pelvic dysfunction symptoms will be assessed in both groups. Pain levels will be measured using the Visual Analog Scale and the McGill Pain Questionnaire Short Form. Additionally, the Fibromyalgia Impact Questionnaire, the Chronic Pelvic Pain Impact Questionnaire, and the Short Form-12 for quality of life assessment will be completed.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Female participants aged 18 and over * Voluntary participation in the study

Exclusion criteria

* Individuals with cognitive impairment * History of pelvic surgery within the last 3 months * Severe cardiac, renal, liver disease, respiratory or endocrine dysfunction, uncontrolled psychiatric illness * Pregnant or breastfeeding women * Individuals with neuropathy or central nervous system disorders * History of neoplasm in the pelvic region

Design outcomes

Primary

Measure	Time frame	Description
Visual Analog Scale	Day 1	The score is obtained by measuring, with a ruler, the distance in millimeters along the 10-cm line from the "no pain" reference point to the mark indicated by the patient, yielding a total score between 0 and 100, where higher values reflect increased pain severity.
Short-Form McGill Pain Questionnaire	Day 1	The Short-Form McGill Pain Questionnaire was developed as a condensed version of the original instrument. Its core section includes 15 pain descriptors, consisting of 11 sensory and 4 affective items, each rated according to intensity on a 4-point scale from 0 (no pain) to 3 (severe pain).
Pelvic Pain Impact Questionnaire	Day 1	The self-administered Pelvic Pain Impact Questionnaire assesses the effect of pelvic pain on daily life. It comprises 8 mandatory and 2 optional items, each rated on a 5-point Likert scale, yielding a total score from 0 to 32, with higher scores indicating greater impact on daily functioning.

Secondary

Measure	Time frame	Description
Fibromyalgia Impact Questionnaire	Day 1	The Fibromyalgia Impact Questionnaire (FIQ) is a self-administered tool consisting of 10 items; the first item includes 11 questions assessing physical functioning, each rated on a 4-point Likert-type scale.

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORBanu Kuran, Professor

Şişli Hamidiye Etfal Training and Research Hospital

Outcome results